NIH-funded research R01 grant

How Candida albicans affects immune responses in the gut

Official title: Commensal Candida albicans primed Th17 immunity

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-10878729 · Data updated 2026-11-12

This study is looking at how a common fungus called Candida albicans affects the immune system in our gut, using mice to learn more about how it activates important immune cells that help fight infections, which could lead to better treatments for gut health issues.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startJuly 1, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$788,565
NIH project number5R01AI168222-02
Project IDNIH-10878729 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with compromised immune systems who are at risk for infections related to Candida albicans.

Less likely to help

Patients who do not have any immune system issues or those not affected by Candida albicans infections may not benefit from this research.

What this research studies

This research investigates how the common fungus Candida albicans interacts with the immune system in the human gut. By using a mouse model, researchers will study how C. albicans colonization leads to the activation of specific immune cells known as Th17 CD4+ T cells. These immune cells are important for protecting against infections, and understanding their behavior could help in developing new treatments for conditions related to gut health and immune response. The study aims to fill gaps in knowledge about the role of fungi in gut immunity and how they may contribute to systemic infections.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for preventing and treating infections caused by Candida albicans, especially in vulnerable populations.

How similar studies have gone: Other research has shown promising results in understanding the immune response to fungal infections, indicating that this approach has potential for success.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Way, Sing Sing — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Way, Sing Sing

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.